NeuroMetrix, Inc. Earnings Conference Call (Q3 2009)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Nov 5 Calls Today's Calls

Call Details NeuroMetrix, Inc. Earnings Conference Call (Q3 2009) Thu, Nov 5, 2009, 8:00 am Eastern Listen to the archived event audio About NeuroMetrix, Inc. (NasdaqGM:NURO) NeuroMetrix, Inc., a medical device company, engages in the development and commercialization of products that aid physicians in the assessment, treatment, and repair of peripheral nerve and spinal cord injuries and disorders, and that provide regional anesthesia and pain control. The company provides ADVANCE NCS/EMG system, a platform for the performance of traditional nerve conduction studies and needle electromyography procedures; NC-stat System, a point-of-service neurodiagnostic solution for the performance of nerve conduction studies; and consumables and accessories for use with its neurodiagnostic equipment. Its products under development include ASCEND, a nerve localization system, which is in the clinical stage of development for minimally invasive delivery of therapeutic agents using a proprietary delivery system for regional anesthesia, pain control, and the treatment of neuropathies; and Andara OFS, an investigational device for the treatment of acute spinal cord injuries. The company offers NC-stat System primarily to primary care and internal medicine physicians; and ADVANCE NCS/EMG System to neurologists, physical medicine and rehabilitation physicians, neurosurgeons, orthopedic and hand surgeons, and pain medicine physicians. It sells its products directly to physician offices, clinics, and hospitals in the United States and internationally. The company was founded in 1996 and is headquartered in Waltham, Massachusetts. More Info: Quote | Chart | Profile | Reports | Research | Msgs | Insider | Financials | Analyst Ratings